Makary resigns, with Diamantas named as acting FDA commissioner
The resignation comes after reports suggested the President was considering firing him.
Regulation
Widespread US shift from prescription to OTC lies in pharma’s hands
Rare disease developers applaud clarity in FDA guidance
FDA’s commissioner vouchers prompt questions about award process
Medical bodies sound alarm over US hepatitis B vaccine vote
FDA appoints Tracy Beth Høeg as fifth CDER head this year
FDA inspection reveals critical supply chain vulnerabilities
EuropaBio calls for “bold approach to investment” amid EU Biotech Act
